MAP2 and Stroke: Our preclinical data suggests a high sensitivity of MAP2 to ischemia, which is also reflected by our analyses of human blood samples, as patients suffering from stroke exhibited significantly higher MAP2 serum levels than patients suffering from TIA (Fig. 6a).